Sinus venous thrombosis as a complication of COVID-19-associated hypercoagulability.

COVID-19 Complications Hypercoagulability SARS-CoV-2 Thrombosis

Journal

The Egyptian journal of neurology, psychiatry and neurosurgery
ISSN: 1110-1083
Titre abrégé: Egypt J Neurol Psychiatr Neurosurg
Pays: England
ID NLM: 0043617

Informations de publication

Date de publication:
2021
Historique:
received: 26 07 2021
accepted: 08 09 2021
entrez: 4 10 2021
pubmed: 5 10 2021
medline: 5 10 2021
Statut: ppublish

Résumé

Sinus venous thrombosis (SVT) is an increasingly recognised complication of not only SARS-CoV-2 infections, but also of SARS-CoV-2 vaccinations. SVT is attributed to hypercoagulability, a common complication of COVID-19, disregarding the severity of the infection. Hypercoagulability in COVID-19 is explained by direct activation of platelets, enhancing coagulation, by direct infection and indirect activation of endothelial cells by SARS-CoV-2, shifting endothelial cells from an anti-thrombotic to a pro-thrombotic state, by direct activation of complement pathways, promoting thrombin generation, or by immune thrombocytopenia, which also generates a thrombogenic state. Since SVT may occur even in anticoagulated COVID-19 patients and may have an unfavourable outcome, all efforts must be made to prevent this complication or to treat it accurately.

Identifiants

pubmed: 34602810
doi: 10.1186/s41983-021-00387-0
pii: 387
pmc: PMC8475476
doi:

Types de publication

Journal Article

Langues

eng

Pagination

132

Informations de copyright

© The Author(s) 2021.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Diagnostics (Basel). 2021 May 26;11(6):
pubmed: 34073620
J Clin Med. 2021 Jul 06;10(14):
pubmed: 34300181
Egypt J Neurol Psychiatr Neurosurg. 2021;57(1):55
pubmed: 33967575
Front Neurol. 2021 Jul 30;12:721146
pubmed: 34393988
Curr Cardiol Rep. 2014 Sep;16(9):523
pubmed: 25073867
Cerebrovasc Dis Extra. 2013 Oct 08;3(1):130-6
pubmed: 24403904
J Clin Med. 2021 Apr 16;10(8):
pubmed: 33923851
Cell Mol Bioeng. 2021 Jun 28;:1-10
pubmed: 34221178
Egypt J Neurol Psychiatr Neurosurg. 2021;57(1):83
pubmed: 34220192
Blood Res. 2021 Jun 30;56(2):61-64
pubmed: 34083499

Auteurs

Sinda Zarrouk (S)

University of Tunis El Manar and Genomics Platform, Pasteur Institute of Tunis, Tunis, Tunisia.

Josef Finsterer (J)

Klinik Landstrasse, Messerli Institute, Postfach 20, 1180 Vienna, Austria.

Classifications MeSH